Hogan Lovells Cadwalader has advised Outlook Therapeutics, Inc. Outlook Therapeutics, Inc. has obtained U.S. Food and Drug Administration (FDA) approval for LYTENAVA™ (bevacizumab-vikg), marking the company’s...
-
Follow Us
-
Search
- North America
- Latin America
September 22, 20264LIAG Argentina Group Secures Two US$20 Million Loans from Banco Galicia
September 22, 20264NCB Financial Group Completes Intra-Group Sale of Cayman Banking Subsidiaries
September 22, 20264Cemig Geração e Transmissão Completes R$1 Billion Debenture Offering
- Europe
- Africa
September 22, 20264Al Baraka Bank Egypt Launches Share Swap Offer for AT Lease
September 21, 20264Genser Energy Secures EUR456 Million Syndicated Facilities for West African Expansion
September 10, 20264Financing Secured for Boujdour II Wind Farm in Morocco
- Middle East
September 18, 20264$100 Million Trade Finance Facility Agreement Reached Between BADEA and The Gambia Government
September 11, 20264ACDIMA Sells 20% Stake in SPIMACO Through Block Trade and Accelerated Bookbuilding
August 11, 20264Zenity Secures $125 Million Series C Funding to Drive AI Agent Security Expansion
- Asia & Pacific
September 22, 20264A$450 Million Student Accommodation Development Launches in Adelaide
September 22, 20264Rentomojo Launches INR 12.56 Billion Initial Public Offering
September 22, 20264Transwarp Technology Lists on Hong Kong Stock Exchange as Specialist Technology Company
- Editorials
September 22, 20264Quinn Emanuel adds London head to Mariana Dam Case
September 18, 20264Ellenoff Grossman & Schole Welcomes Evelyn Louie-Nam as new Chief Financial Officer
September 17, 20264Bignon Lebray appoints Pierre-Emmanuel Scherrer to its Executive Board
- In & Out
September 22, 20264Paul, Weiss Adds Deidre Kalenderian as Executive Compensation Partner in New York
September 22, 20264Dias Carneiro Advogados Announces New Counsels: Fernando Becker Mau and Cíntia Rosa
September 22, 20264Partners Michael Resch and Smitha Stansbury Join Sidley to Expand Global Life Sciences Practices